Influenza vaccine is able to induce post-infection antibodies to SARS-CoV-2 in medical staff

Influenza vaccination contributes to the favorable course and outcome of COVID-19. The aim of our study was to study the effect of influenza and pneumococcal vaccines on the level of IgG antibodies (AT) to SARS-CoV-2 among medical personnel at the beginning of the COVID-19 pandemic. We present the d...

Full description

Saved in:
Bibliographic Details
Main Authors: M. P. Kostinov, N. Yu. Nastaeva, N. F. Nikityuk, N. K. Akhmatova, M. I. Albahansa, S. V. Yushkova, N. P. Andreeva, A. M. Kostinova, A. V. Linok, M. N. Loktionova, I. A. Khrapunova
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2025-01-01
Series:Медицинская иммунология
Subjects:
Online Access:https://www.mimmun.ru/mimmun/article/view/2982
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Influenza vaccination contributes to the favorable course and outcome of COVID-19. The aim of our study was to study the effect of influenza and pneumococcal vaccines on the level of IgG antibodies (AT) to SARS-CoV-2 among medical personnel at the beginning of the COVID-19 pandemic. We present the data on assessment of specific immune response to the influenza virus and SARS-CoV-2 in 266 medical workers 6 months after immunization against influenza and/or pneumococcal infection (without vaccinations against COVID-19) over the 2020-2021, by comparing the results with respective characteristic in 281 employees with no history of vaccinations is presented.We have found that the proportion of medical workers with a protective (≥ 1:40) antibody levels to influenza virus 6 months after vaccination in groups of participants reaches a protective (≥ 70%) value only in persons who received a monovaccine against pneumococcal infection (78.6%) as compared with persons vaccinated with a monovaccine against influenza (61.7%) (p < 0.001), as well as with a group of workers immunized against influenza in combination with the S. pneumoniae vaccine (68.9%) (p < 0.01). Hence, the pneumococcal vaccine is able to induce the synthesis of IgG-AT to influenza virus reaching protective values.An analysis of the group with seropositivity to influenza virus (IgG-AT ≥ 1:10) and their comparisons with persons seroprevalent to COVID-19 showed that the proportion of seropositive individuals among medical staff vaccinated against seasonal influenza after 6 months (indicating a probable asymptomatic form of COVID-19) is increased. It comprised 65.4% (p = 0.026) in the group vaccinated with mono-flu, and 64.5% (p = 0.04) in the group vaccinated with combined influenza and pneumococcus, being higher than among the non-immunized workers (48.8%).In summary, the results of our study show that influenza vaccination acts as an inducer of humoral immunity not only to the influenza virus, but also to the recently transmitted SARS-CoV-2 infection.
ISSN:1563-0625
2313-741X